Physician

Chaudhry M Mushtaq, MD

According to 2025 Medicare claims, Chaudhry Mushtaq, MD (NPI: 1942281399) practices medical oncology in the Columbia, SC market, with the plurality of this provider's patient population coming from Richland, SC. This provider's primary affiliated billing organization is SOUTH CAROLINA ONCOLOGY ASSOC PA (NPI: 1467406918; TIN: 570787600) and primary practice location at 29210-8239. Mushtaq is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Mushtaq's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 968 traditional Medicare patients, billed 297,386 HCPCS/CPT codes, and received $4,205,675 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 337 prescription claims across 128 beneficiaries totaling $679,238 in drug costs, led by Exemestane (Exemestane). DME data shows 62 claims. Open Payments data shows 138 records totaling $3,020. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,389,057 to $4,205,675. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,410,878 and ending at $679,238. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,430 to $1,589.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	971	244,261	$2,389,057
2016	899	265,111	$2,751,840
2017	997	359,553	$3,507,913
2018	938	358,625	$3,732,854
2019	944	331,154	$3,991,868
2020	879	315,327	$4,274,567
2021	851	367,746	$4,356,192
2022	823	314,773	$3,754,957
2023	864	275,552	$3,428,407
2024	968	297,386	$4,205,675

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	196	967	$1,410,878
2016	193	889	$733,843
2017	226	1,033	$936,504
2018	178	984	$774,297
2019	194	843	$1,032,857
2020	182	766	$1,192,633
2021	132	549	$999,602
2022	127	409	$807,677
2023	96	321	$606,406
2024	128	337	$679,238

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	266	$13,985
2016	N/R	339	$48,231
2017	22	461	$51,023
2018	58	301	$12,846
2019	N/R	71	$5,977
2020	N/R	45	$4,437
2021	N/R	80	$3,918
2022	N/R	46	$2,972
2023	N/R	135	$74,060
2024	N/R	62	$34,896

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	531	1,301	$97
36415	Insertion of needle into vein for collection of blood sample	519	2,120	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	501	1,968	$8
80076	Liver function blood test panel	501	1,948	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	509	2,044	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Exemestane	Exemestane	15	810	$1,146
Ondansetron Odt	Ondansetron	38	368	$1,018
Letrozole	Letrozole	23	1,530	$731
Dexamethasone	Dexamethasone	31	963	$517
Prochlorperazine Maleate	Prochlorperazine Maleate	33	247	$271

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	14	$25,003
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	16	$5,866
B4224	Parenteral nutrition administration kit, per day	N	N/R	16	$3,050
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	16	$977

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	138	$3,020	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chaudhry M. Mushtaq, MD?

Tedicare shows public-source Medicare data for Chaudhry M. Mushtaq, MD (NPI 1942281399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chaudhry M. Mushtaq, MD have ACO affiliation data?

Chaudhry M. Mushtaq, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Chaudhry M. Mushtaq, MD?

Chaudhry M. Mushtaq, MD is linked to SOUTH CAROLINA ONCOLOGY ASSOC PA (billing NPI 1467406918) in the available physician profile data.

Does Chaudhry M. Mushtaq, MD have Open Payments data?

Chaudhry M. Mushtaq, MD has 138 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.